Executive Director, MIT Center for Biomedical Innovation
Dr. Hirsch is the Executive Director of the MIT Center for Biomedical Innovation (CBI) and NEWDIGS, a "think and do tank" that re-engineers pharmaceutical innovation to deliver more value faster to patients, in ways that work for all stakeholders. NEWDIGS' flagship project on "Adaptive Biomedical Innovation (ABI)" helped inspire the EMA's Adaptive Pathways pilot project (2014-2016). Under her leadership, NEWDIGS continues to advance other critical enablers of ABI such as efficacy-to-effectiveness (E2E) strategies, tools, and systems; precision financing models for curative therapies; and simulation methods/tools for collaborative innovation. Hirsch has held a number of leadership roles that leverage her clinical background (Internal Medicine, Emergency Medicine, Psychiatry) both in industry (Millennium Pharmaceuticals) and academia (Harvard, Brown, Tufts).